Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C as Add-on Therapy in Acute Herpes Zoster
NCT05561257Phase 2Terminated
- Sponsor
- Pascoe
- Start
- Jul 2020
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of C-vimin in herpes zoster (HZ) (4 arms), sponsored by Pascoe. Primary endpoint: Mean neuropathic pain. Started Jul 2020; status: terminated.
02
Drugs
C-vimin
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05561257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05561257.